KUALA LUMPUR: Pharmaniaga Bhd
's wholly owned subsidiary Pharmaniaga Research Centre Sdn Bhd has entered into a memorandum of understanding with the National Institutes of Biotechnology Malaysia (NIBM) to collaborate on vaccine research and development.
It said in a filing with Bursa Malaysia that the MoU shall come into effect from Nov 1, 2021, and shall remain in force for a period of three years or until termination of the MoU, whichever is earlier.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
